(Q38461322)

English

Inhibitory effect of ginsenoside Rg1 on extracellular matrix production via extracellular signal-regulated protein kinase/activator protein 1 pathway in nasal polyp-derived fibroblasts

scientific article published on 22 June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Inhibitory effect of ginsenoside Rg1 on extracellular matrix production via extracellular signal-regulated protein kinase/activator protein 1 pathway in nasal polyp-derived fibroblasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

extracellular matrix

0 references

author name string

Jung-Sun Cho

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

You-Mi Moon

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ji-Young Um

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jun-Hyeok Moon

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Il-Ho Park

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Heung-Man Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

22 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Experimental Biology and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

237

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

663-669

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Nasal polyposis: an update: editorial review

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate.

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Panax ginseng pharmacology: a nitric oxide link?

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Ginseng pharmacology: multiple constituents and multiple actions

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

The role of tubular epithelial-mesenchymal transition in progressive kidney disease.

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Cardiovascular protection by ginsenosides and their nitric oxide releasing action

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Pharmacological activity of sanchi ginseng (Panax notoginseng).

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Non-Smad signaling pathways

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Comparative Assessment of Cell Proliferation and Accumulation of Extracellular Matrix in Nasal Polyps

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2012.011342

21 January 2018

Identifiers

10.1258/EBM.2012.011342

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

release_w5xi5fgvwvaljolcaypctpj7ve

1 reference

https://api.fatcat.wiki/v0/release/w5xi5fgvwvaljolcaypctpj7ve

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38461322&oldid=1839221364"